FR2995212B1 - Composition pharmaceutique comprenant de la lacidipine et procede de preparation - Google Patents

Composition pharmaceutique comprenant de la lacidipine et procede de preparation

Info

Publication number: FR2995212B1
Authority: FR; France
Prior art keywords: lacidipine; preparation; pharmaceutical composition; pharmaceutical; composition
Prior art date: 2012-09-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR1358691A

Other languages

English (en)

Other versions

FR2995212A1 (fr

Inventor

Piero Poli

Michela Carcano

Gabriele Vecchi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

RIVOPHARM SA

Original Assignee

RIVOPHARM SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-09-10

Filing date

2013-09-10

Publication date

2017-09-01

2013-09-10 Application filed by RIVOPHARM SA filed Critical RIVOPHARM SA

2014-03-14 Publication of FR2995212A1 publication Critical patent/FR2995212A1/fr

2017-09-01 Application granted granted Critical

2017-09-01 Publication of FR2995212B1 publication Critical patent/FR2995212B1/fr

Status Expired - Fee Related legal-status Critical Current

2033-09-10 Anticipated expiration legal-status Critical

Links

GKQPCPXONLDCMU-CCEZHUSRSA-N lacidipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C GKQPCPXONLDCMU-CCEZHUSRSA-N 0.000 title 1
229960004340 lacidipine Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
238000002360 preparation method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

FR1358691A 2012-09-10 2013-09-10 Composition pharmaceutique comprenant de la lacidipine et procede de preparation Expired - Fee Related FR2995212B1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP12183762		2012-09-10

Publications (2)

Publication Number	Publication Date
FR2995212A1 FR2995212A1 (fr)	2014-03-14
FR2995212B1 true FR2995212B1 (fr)	2017-09-01

Family

ID=46826329

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR1358691A Expired - Fee Related FR2995212B1 (fr)	2012-09-10	2013-09-10	Composition pharmaceutique comprenant de la lacidipine et procede de preparation

Country Status (6)

Country	Link
EP (1)	EP2705839B1 (fr)
FR (1)	FR2995212B1 (fr)
HR (1)	HRP20180781T1 (fr)
IT (1)	ITMI20131485A1 (fr)
LT (1)	LT2705839T (fr)
PL (1)	PL2705839T3 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN112168798A (zh) *	2020-10-23	2021-01-05	哈药集团技术中心	一种拉西地平片的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ212895A (en)	1984-08-22	1988-07-28	Glaxo Spa	1,4-dihydropyridine derivatives and pharmaceutical compositions
SI9300504A (en)	1993-09-28	1995-04-30	Krka	Process for preparation solid dispersions and deposits of calcium antagonist dihidropyrimidine derivates and pharmaceutical compositions comprising the same
WO2000027397A1 (fr) *	1998-11-06	2000-05-18	Glaxo Group Limited	Medicaments antihypertenseurs a base de lacidipine et de telmisartan
EP1868577A4 (fr)	2005-04-15	2009-12-09	Reddys Lab Inc Dr	Particules de lacidipine
KR20110032608A (ko) *	2009-09-23	2011-03-30	대한뉴팜(주)	라시디핀을 함유하는 정제의 약제학적 조성물

2013
- 2013-09-09 IT IT001485A patent/ITMI20131485A1/it unknown
- 2013-09-09 PL PL13183603T patent/PL2705839T3/pl unknown
- 2013-09-09 LT LTEP13183603.3T patent/LT2705839T/lt unknown
- 2013-09-09 EP EP13183603.3A patent/EP2705839B1/fr active Active
- 2013-09-10 FR FR1358691A patent/FR2995212B1/fr not_active Expired - Fee Related
2018
- 2018-05-18 HR HRP20180781TT patent/HRP20180781T1/hr unknown

Also Published As

Publication number	Publication date
FR2995212A1 (fr)	2014-03-14
ITMI20131485A1 (it)	2014-03-11
EP2705839A1 (fr)	2014-03-12
EP2705839B1 (fr)	2018-02-21
PL2705839T3 (pl)	2018-07-31
HRP20180781T1 (hr)	2018-07-13
LT2705839T (lt)	2018-06-11

Similar Documents

Publication	Publication Date	Title
BR112014002621A2 (pt)	2017-12-12	anticorpo, composição farmacêutica, combinação farmacêutica, dna e método de tratamento
BR112014021103A8 (pt)	2018-01-23	anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo
IL233663B (en)	2018-04-30	Indolizine compounds, processes for their preparation and pharmaceutical compositions containing them
BR112014023937A2 (pt)	2018-04-17	composição farmacêutica, agente farmacêutico de combinação e método de tratamento
PT2729151T (pt)	2021-05-25	Composição farmacêutica, métodos de tratamento e suas utilizações
DK3181128T3 (da)	2023-06-06	Farmaceutisk nilotinib-sammensætning
EP2731594A4 (fr)	2014-12-31	Préparation sous forme de capsule comprenant du montélukast et de la lévocétirizine
BR112013014644A2 (pt)	2017-03-07	composição farmacêutica e complexo
EP2702989A4 (fr)	2014-12-31	Composition pharmaceutique stable
HUE037512T2 (hu)	2018-08-28	Cikloalkilsav-származék, eljárás elõállítására, és felhasználása gyógyszerként
EP2642979A4 (fr)	2014-09-17	Composition pharmaceutique
FR2958157B1 (fr)	2012-06-29	Composition cosmetique et pharmaceutique comprenant du n-acetyl-glucosamine-6-phosphate
EP2815752A4 (fr)	2015-07-29	Composition pharmaceutique orale
CL2014003283A1 (es)	2016-04-01	Formulación farmacéutica.
EP2723320A4 (fr)	2014-12-03	Composition pharmaceutique liquide comprenant de la nitisinone
EP2815753A4 (fr)	2015-07-01	Composition pharmaceutique orale
BR112015010271A2 (pt)	2017-07-11	produto de comicronização, composição farmacêutica e seus usos
BR112013017267A2 (pt)	2018-01-09	formulação de lipossomas, suspensão e composição farmacêutica
CO7020911A2 (es)	2014-08-11	Sistema para la administración de fármacos
EP2687532A4 (fr)	2014-08-13	Nouveau dérivé octahydrothiénoquinoline, composition pharmaceutique comprenant le dérivé, et utilisation de ceux-ci
BR112014003556A2 (pt)	2017-03-21	método de tratamento de vírus, e, composição farmacêutica
DK3473255T3 (da)	2022-04-04	Farmaceutisk formulering omfattende ciclesonid
SMT201600243B (it)	2016-08-31	Composizioni farmaceutiche comprendenti anakinra senza citrato
EP2787986A4 (fr)	2015-07-15	Acides dioïques de tétraméthyle deutérés, compositions les comprenant et leurs utilisations
BR112014001959A2 (pt)	2017-02-21	derivado de camptotencina solúvel em água, composição farmacêutica e aplicação dos mesmos

Legal Events

Date	Code	Title	Description
2015-09-22	PLFP	Fee payment	Year of fee payment: 3
2016-09-09	PLFP	Fee payment	Year of fee payment: 4
2017-09-21	PLFP	Fee payment	Year of fee payment: 5
2018-09-27	PLFP	Fee payment	Year of fee payment: 6
2019-09-20	PLFP	Fee payment	Year of fee payment: 7
2020-09-21	PLFP	Fee payment	Year of fee payment: 8
2022-06-10	ST	Notification of lapse	Effective date: 20220505